Role of SARS-CoV-2 spike-protein-induced activation of microglia and mast cells in the pathogenesis of neuro-COVID
TC Theoharides, D Kempuraj - Cells, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19). About 45% of COVID-19 patients experience several symptoms a …
disease 2019 (COVID-19). About 45% of COVID-19 patients experience several symptoms a …
The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of
coronavirus disease 2019 (COVID-19). SARS-CoV-2, is a positive-sense single-stranded …
coronavirus disease 2019 (COVID-19). SARS-CoV-2, is a positive-sense single-stranded …
The pandemic brain: Neuroinflammation in non-infected individuals during the COVID-19 pandemic
While COVID-19 research has seen an explosion in the literature, the impact of pandemic-
related societal and lifestyle disruptions on brain health among the uninfected remains …
related societal and lifestyle disruptions on brain health among the uninfected remains …
COVID-19: inflammatory profile
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of
coronavirus disease 2019 (COVID-19), has resulted in a pandemic that has had widespread …
coronavirus disease 2019 (COVID-19), has resulted in a pandemic that has had widespread …
Neurological manifestation of SARS-CoV-2 induced inflammation and possible therapeutic strategies against COVID-19
There are regular reports of extrapulmonary infections and manifestations related to the
ongoing COVID-19 pandemic. Coronaviruses are potentially neurotropic, which renders …
ongoing COVID-19 pandemic. Coronaviruses are potentially neurotropic, which renders …
COVID-19: immunology, immunopathogenesis and potential therapies
Abstract The Coronavirus Disease-2019 (COVID-19) imposed public health emergency and
affected millions of people around the globe. As of January 2021, 100 million confirmed …
affected millions of people around the globe. As of January 2021, 100 million confirmed …
Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics
The development of long-term symptoms of coronavirus disease 2019 (COVID-19) more
than four weeks after primary infection, termed “long COVID” or post-acute sequela of …
than four weeks after primary infection, termed “long COVID” or post-acute sequela of …
Unraveling the mystery surrounding post-acute sequelae of COVID-19
RK Ramakrishnan, T Kashour, Q Hamid… - Frontiers in …, 2021 - frontiersin.org
More than one year since its emergence, corona virus disease 2019 (COVID-19) is still
looming large with a paucity of treatment options. To add to this burden, a sizeable subset of …
looming large with a paucity of treatment options. To add to this burden, a sizeable subset of …
Neurological consequences of COVID-19: what have we learned and where do we go from here?
Abstract The coronavirus disease-19 (COVID-19) pandemic is an unprecedented worldwide
health crisis. COVID-19 is caused by SARS-CoV-2, a highly infectious pathogen that is …
health crisis. COVID-19 is caused by SARS-CoV-2, a highly infectious pathogen that is …
[HTML][HTML] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives
G Vargas, LHM Geraldo, NG Salomão, MV Paes… - Brain, behavior, & …, 2020 - Elsevier
In December 2019, a pneumonia outbreak was reported in Wuhan, Hubei province, China.
Since then, the World Health Organization declared a public health emergency of …
Since then, the World Health Organization declared a public health emergency of …